| Date Filed | Type | Description |
| 10/10/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/11/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/11/2023 |
8-K
| Quarterly results |
| 06/28/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/27/2023 |
4
| Hwang Kuk Hyoun (CEO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Acquired 20,000 shares
@ $0
Disposed of 20,000 options to buy
@ $11.5, valued at
$230k
|
|
| 03/27/2023 |
4
| Yoo David Jin (CFO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Granted 20,000 shares
@ $0
Granted 20,000 options to buy
@ $11.5, valued at
$230k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/28/2023 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/23/2023 |
4
| Hwang Kuk Hyoun (CEO) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Acquired 225,000 shares
@ $0
Disposed of 4,500 shares
@ $0 |
|
| 02/23/2023 |
4
| Bellevue Global Life Science Investors LLC (10% Owner) has filed a Form 4 on Bellevue Life Sciences Acquisition Corp.|
Txns:
| Acquired 225,000 shares
@ $0
Disposed of 4,500 shares
@ $0 |
|
| 02/13/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 02/10/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/09/2023 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 02/09/2023 |
3
| Chung In Chul (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Roberts Rad (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Yoo David Jin (CFO) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Euh Hosun (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Bellevue Global Life Science Investors LLC (10% Owner) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| REED STEVEN (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Park Jin Whan (Director Nominee) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Whang Jun Chul (Director) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/09/2023 |
3
| Hwang Kuk Hyoun (See Remarks) has filed a Form 3 on Bellevue Life Sciences Acquisition Corp. |
| 02/08/2023 |
8-A12B/A
| Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] |
| 01/20/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 11/04/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 10/07/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 05/16/2022 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 05/13/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 05/11/2022 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 05/10/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |